Company Overview

Update
Status:
Acquired by OPKO Health
Headquarters:
Bannockburn, IL
Categories:
Biotechnology
Description:
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat

Detailed Description

Update

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    2333 Waukegan Road

    Suite E100

    Bannockburn, IL 60015

    USA